LifeStance Health Group Inc. (NASDAQ: LFST) stock jumped 6.21% on Friday to $7.18 against a previous-day closing price of $6.76. With 1.18 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.79 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $7.26 whereas the lowest price it dropped to was $6.66. The 52-week range on LFST shows that it touched its highest point at $24.98 and its lowest point at $4.77 during that stretch. It currently has a 1-year price target of $10.00.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LFST was up-trending over the past week, with a rise of 22.53%, but this was up by 29.14% over a month. Three-month performance surged to 6.37% while six-month performance fell -6.27%. The stock lost -70.28% in the past year, while it has lost -24.58% so far this year. A look at the trailing 12-month EPS for LFST yields -1.06 with Next year EPS estimates of -0.14. For the next quarter, that number is -0.14. This implies an EPS growth rate of -26.00% for this year and 81.30% for next year.
Float and Shares Shorts:
At present, 350.85 million LFST shares are outstanding with a float of 316.05 million shares on hand for trading. On Jul 14, 2022, short shares totaled 9.7 million, which was 2.59% higher than short shares on Jun 14, 2022. In addition to Mr. Michael K. Lester as the firm’s Chairman of Directors, CEO & Pres, Mr. Jesse Michael Bruff serves as its CFO & Treasurer.
Through their ownership of 83.70% of LFST’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 63.55% of LFST, in contrast to 5.00% held by mutual funds. Shares owned by individuals account for 14.13%. As the largest shareholder in LFST with 9.92% of the stake, Fidelity Management & Research Co holds 37,142,319 shares worth 37,142,319. A second-largest stockholder of LFST, The Vanguard Group, Inc., holds 6,104,396 shares, controlling over 1.63% of the firm’s shares. Stockbridge Partners LLC is the third largest shareholder in LFST, holding 5,294,610 shares or 1.41% stake. With a 2.89% stake in LFST, the Fidelity Advisor Series I -Growth is the largest stakeholder. A total of 10,806,163 shares are owned by the mutual fund manager. The Fidelity Select Medical Technolog, which owns about 1.14% of LFST stock, is the second-largest Mutual Fund holder. It holds 4,250,000 shares valued at 23.63 million. Fidelity Select Port. – Health Ca holds 1.14% of the stake in LFST, owning 4,250,000 shares worth 23.63 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LFST since 7 analysts follow the stock currently. There are 3 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 4 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With LFST analysts setting a high price target of $15.00 and a low target of $7.00, the average target price over the next 12 months is $9.83. Based on these targets, LFST could surge 108.91% to reach the target high and fall by -2.51% to reach the target low. Reaching the average price target will result in a growth of 36.91% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. LFST will report FY 2022 earnings on 03/10/2023. Analysts have provided yearly estimates in a range of -$0.53 being high and -$0.64 being low. For LFST, this leads to a yearly average estimate of -$0.56. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. LifeStance Health Group Inc. surprised analysts by $0.01 when it reported -$0.18 EPS against a consensus estimate of -$0.19. The surprise factor in the prior quarter was -$0.05. Based on analyst estimates, the high estimate for the next quarter is -$0.15 and the low estimate is -$0.16. The average estimate for the next quarter is thus -$0.16.
Summary of Insider Activity:
Insiders traded LFST stock several times over the past three months with 0 Buys and 9 Sells. In these transactions, 0 shares were bought while 664,621 shares were sold. The number of buy transactions has increased to 11 while that of sell transactions has risen to 13 over the past year. The total number of shares bought during that period was 1,167,589 while 769,737 shares were sold.